Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2 programme ...
Sometimes you need to use a computer and you don’t have a spare keyboard and mouse on hand. [KoStard] figured an iPhone could ...